Literature DB >> 12965092

Fetal hypoxemia on a molecular level: adaptive changes in the hypothalamic-pituitary-adrenal (HPA) axis and the lungs.

Geert Braems1.   

Abstract

The development of diseases in later life, such as diabetes type II, hypertension and cardiovascular disease, is linked to abnormal intrauterine conditions that reduce birth weight. Obviously, fetal development can be disturbed so profoundly, that fetal programming is changed permanently. We have examined the effects of hypoxia, or more precisely hypoxemia, on the fetal hypothalamic-pituitary-adrenal (HPA) axis and lungs using molecular biology techniques in order to elucidate the underlying mechanisms. Chronically catheterized fetal sheep were subjected to a hypoxemia (48 h) without change in arterial pH or paCO2. Major changes occurred, although the degree of hypoxemia was just moderate. There was a transient increase in the fetal plasma ACTH-concentrations with an upregulation of the cortisol-concentrations, which was more pronounced in the older, hypoxemic fetuses (134-136 days of gestation) than in the younger, hypoxemic animals (126-130 days of gestation; term is 145 days). There was an unique, differential regulation for pro-opiomelanocortin messenger RNA (mRNA), the precursor molecule of e.g. ACTH, in the pars distalis and pars intermedia of the pituitary gland. This finding supported the increased bioactivity besides the increased concentrations for ACTH. Simultaneously, there was an increase in the mRNAs of the ACTH-receptor and of the steroid-synthesizing enzymes in the fetal adrenal gland of the older, hypoxemic fetuses. No changes in the fetal plasma androstenedione-concentrations were observed. Clearly, there was a selective increase of the cortisol-synthesis. Growth and maturation of the fetal lung might also have been affected, because of the increase in surfactant-protein A mRNA in the older, hypoxemic animals and the decrease in the insulin-like growth factor-I and its binding protein-5 mRNA in the younger, hypoxemic fetuses. In summary, even a moderate degree of hypoxemia was shown to affect the different levels of fetal organism profoundly, offering a pathophysiological basis for changes in fetal development.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12965092     DOI: 10.1016/s0301-2115(03)00174-x

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  6 in total

1.  Fetal origins of neonatal lung disease: understanding the pathogenesis of bronchopulmonary dysplasia.

Authors:  Karen K Mestan; Robin H Steinhorn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-09-30       Impact factor: 5.464

2.  Evaluation of postmortem serum and cerebrospinal fluid growth hormone levels in relation to the cause of death in forensic autopsy.

Authors:  Takaki Ishikawa; Tomomi Michiue; Hitoshi Maeda
Journal:  Hum Cell       Date:  2011-01-28       Impact factor: 4.174

3.  Use of inhaled corticosteroids during the first trimester of pregnancy and the risk of congenital malformations among women with asthma.

Authors:  Lucie Blais; Marie-France Beauchesne; Evelyne Rey; Jean-Luc Malo; Amélie Forget
Journal:  Thorax       Date:  2006-11-22       Impact factor: 9.139

4.  Leptin receptor antagonist treatment ameliorates the effects of long-term maternal hypoxia on adrenal expression of key steroidogenic genes in the ovine fetus.

Authors:  Charles A Ducsay; Ken Furuta; Vladimir E Vargas; Kanchan M Kaushal; Krista Singleton; Kimberly Hyatt; Dean A Myers
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-01-23       Impact factor: 3.619

Review 5.  Gestational Hypoxia and Developmental Plasticity.

Authors:  Charles A Ducsay; Ravi Goyal; William J Pearce; Sean Wilson; Xiang-Qun Hu; Lubo Zhang
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

6.  Born from pre-eclamptic pregnancies predisposes infants to altered cortisol metabolism in the first postnatal year.

Authors:  Fiona Broughton Pipkin; Hiten D Mistry; Chandrima Roy; Bernhard Dick; Jason Waugh; Rebecca Chikhi; Lesia O Kurlak; Markus G Mohaupt
Journal:  Endocr Connect       Date:  2015-09-16       Impact factor: 3.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.